Hallucinogens, Psychedelics, and Tryptamines: 2024 Overview
This session explores the current landscape of hallucinogens, psychedelics, and tryptamines as of 2024, delving into their cultural, medical, and law enforcement implications. It examines the resurgence of interest in these substances, highlighting recent findings on the street, and shifts in public perception.
Key topics include the use of various psychedelics, including psilocybin, LSD, and DMT, as well as their effects. The overview also discusses the evolving legal parameters surrounding these compounds, and the new focus on decriminalization efforts.
Furthermore, this session will touch on mental health treatment, exploring its use in addressing conditions such as depression, anxiety, PTSD, and addiction.
